Hypermobile Ehlers-Danlos Syndrome
12
1
1
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
25.0%
3 terminated out of 12 trials
66.7%
-19.8% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Hypermobile Ehlers-Danlos Syndrome - Transcutaneous Auricular Neuromodulation
Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Oxytocin for Hypermobile Ehlers-Danlos Syndrome
Online Pilates Exercise for People With Hypermobility
TMD-specific Physiotherapy in hEDS Patients Individuals With Hypermobile Ehlers-Danlos Syndrome
Central Sensitization and Physical Activity in Adolescents With HSD/hEDS
Comprehensive Assessment of Nutrition and Dietary Intervention in Hypermobile Ehlers Danlos Syndrome
Characterization of Bleeding Disorders in EDS
Dynamic Stability Exercises in Patients With Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorder
Lung Volume Perception and Impact of a Cognitive Task on Ventilation in Hypermobile Ehlers-Danlos Syndrome.
Patient-based Care Versus Standard Care for Patients With hEDS/HSD and Multidirectional Shoulder Instability